Evidence map›Paper›PMID 34686985›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2022

High-Throughput Screening Assays to Identify Plant Natural Products with Antifungal Properties Against Fusarium oxysporum.

Yong Zhang, Pei-Lun Kao, Akaansha Rampal, Sibongile Mafu, Sergey Savinov, Li-Jun Ma

Open access · greenAbstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yong ZhangDepartment of Biochemistry and Molecular Biology, University of Massachusetts Amherst, Amherst, MA, USA.
Pei-Lun KaoDepartment of Biochemistry and Molecular Biology, University of Massachusetts Amherst, Amherst, MA, USA.
Akaansha RampalDepartment of Biochemistry and Molecular Biology, University of Massachusetts Amherst, Amherst, MA, USA.
Sibongile MafuDepartment of Biochemistry and Molecular Biology, University of Massachusetts Amherst, Amherst, MA, USA.
Sergey SavinovDepartment of Biochemistry and Molecular Biology, University of Massachusetts Amherst, Amherst, MA, USA. Sergey.Savinov@tufts.edu.
Li-Jun MaDepartment of Biochemistry and Molecular Biology, University of Massachusetts Amherst, Amherst, MA, USA. lijun@biochem.umass.edu.
University of Massachusetts Amherst · USNational Institute of Neurological Disorders and Stroke · US

Funding

Identify virulence factors that facilitate Fusarium keratitisR01EY030150 · NEI · UNIVERSITY OF MASSACHUSETTS AMHERST · PI MA, LI-JUN · 2019 to 2023
$1.9M
NEI NIH HHS R01 EY030150
6 · The paper itself

Abstract

Fusarium oxysporum is a cross-kingdom fungal pathogen that not only causes devastating plant vascular diseases but can also opportunistically infect humans. Here we describe two high-throughput screening assays, a resazurin cell viability assay and an optical density assay, to screen natural products from cultured plant cells with antifungal properties against a clinical isolate of F. oxysporum. After elicitation by applying methyl jasmonate or by co-culture with F. oxysporum, as an abiotic elicitor and a biotic elicitor, respectively, we identified three cell lines that produce materials that inhibit fungal growth. Our procedure validates the powerful potential of combining high-throughput methods for the discovery of novel anti-pathogenic leads.

Indexed as

Biological ProductsFusariumAntifungal AgentsHigh-Throughput Screening AssaysHumansPlant DiseasesAntifungal AgentsBiological ProductsAntifungal screenAssay developmentFusarium oxysporumHigh-throughputPlant cell culture collection

Identifiers

PMID34686985
PMCPMC9022449
OpenAlexW3207965678

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.